Scott McKane

1.2k total citations
31 papers, 845 citations indexed

About

Scott McKane is a scholar working on Physiology, Endocrine and Autonomic Systems and Speech and Hearing. According to data from OpenAlex, Scott McKane has authored 31 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 14 papers in Endocrine and Autonomic Systems and 10 papers in Speech and Hearing. Recurrent topics in Scott McKane's work include Obstructive Sleep Apnea Research (22 papers), Neuroscience of respiration and sleep (14 papers) and Dysphagia Assessment and Management (10 papers). Scott McKane is often cited by papers focused on Obstructive Sleep Apnea Research (22 papers), Neuroscience of respiration and sleep (14 papers) and Dysphagia Assessment and Management (10 papers). Scott McKane collaborates with scholars based in United States, Germany and Poland. Scott McKane's co-authors include Sheila J. Gibson, Xiaohong Qiu, Richard L. Miller, John P. Vasilakos, Patricia Fitzgerald‐Bocarsly, Keith Gorden, Ross M. Kedl, Lisa M. Rogers, Mark A. Tomai and James H. Lee and has published in prestigious journals such as CHEST Journal, SLEEP and British Journal of Dermatology.

In The Last Decade

Scott McKane

25 papers receiving 819 citations

Peers

Countries citing papers authored by Scott McKane

Since Specialization

Citations

This map shows the geographic impact of Scott McKane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott McKane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott McKane more than expected).

Fields of papers citing papers by Scott McKane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott McKane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott McKane. The network helps show where Scott McKane may publish in the future.

Co-authorship network of co-authors of Scott McKane

This figure shows the co-authorship network connecting the top 25 collaborators of Scott McKane. A scholar is included among the top collaborators of Scott McKane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott McKane. Scott McKane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real world characteristics of central sleep apnea: a review of 29,000 consecutive patients undergoing polysomnography 2025 ·Sleep And Breathing ·Sanjay R. Patel, Michael V. Genuardi, Rebecca DeSensi, Marat Fudim, Lars H. Lund, Reena Mehra, Robin Germany, Scott McKane	0
2	Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes 2025 ·Journal of Clinical Sleep Medicine ·(unknown), Alan R. Schwartz, Shahrokh Javaheri, Robin Germany, Scott McKane, Timothy I. Morgenthaler	0
3	Determinants of transvenous phrenic nerve stimulation-induced improvements in left ventricular function in central sleep apnea and heart failure 2025 ·SLEEP ·Ali Azarbarzin, (unknown), Daniel Vena, Ludovico Messineo, Susan Redline, Scott McKane, Andrew Wellman, Shahrokh Javaheri, Scott A. Sands	0
4	Phrenic nerve stimulation for central sleep apnea: a single institution experience 2024 ·Sleep And Breathing ·(unknown), Ralph Augostini, Scott McKane, Meena Khan	1
5	Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea 2023 ·SLEEP ·Mathias Baumert, Dominik Linz, Scott McKane, Sarah A. Immanuel	1
6	Design of the remedē System Therapy (rēST) study: A prospective non-randomized post-market study collecting clinical data on safety and effectiveness of the remedē system for the treatment of central sleep apnea 2022 ·Sleep Medicine ·Lee R. Goldberg, Henrik Fox, Christoph Stellbrink, Biykem Bozkurt, John Boehmer, (unknown), Rahul N. Doshi, Timothy I. Morgenthaler, Wayne C. Levy, Timothy E. Meyer, Scott McKane, Robin Germany	0
7	Transvenous phrenic nerve stimulation to treat central sleep apnoea in patients with heart failure may improve sleep, quality of life, and symptoms 2022 ·European Journal of Cardiovascular Nursing ·Loreena Hill, Timothy E. Meyer, Scott McKane, Mitja Lainščak, Qanta A. Ahmed	3
8	Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes 2021 ·Nature and Science of Sleep ·Maria Rosa Costanzo, Shahrokh Javaheri, Piotr Ponikowski, Olaf Oldenburg, Ralph Augostini, Lee R. Goldberg, Christoph Stellbrink, Henrik Fox, Alan R. Schwartz, Sanjaya Gupta, Scott McKane, Timothy E. Meyer, William T. Abraham	30
9	Transvenous phrenic nerve stimulation improves central sleep apnea, sleep quality, and quality of life regardless of prior positive airway pressure treatment 2021 ·Sleep And Breathing ·Alan R. Schwartz, Lee R. Goldberg, Scott McKane, Timothy I. Morgenthaler	6
10	Transvenous phrenic nerve stimulation to treat idiopathic central sleep apnea 2020 ·Journal of Clinical Sleep Medicine ·Shahrokh Javaheri, Scott McKane	5
11	Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea 2020 ·Journal of Cardiovascular Translational Research ·Olaf Oldenburg, Maria Rosa Costanzo, Robin Germany, Scott McKane, Timothy E. Meyer, Henrik Fox	22
12	Transvenous phrenic nerve stimulation for central sleep apnea is safe and effective in patients with concomitant cardiac devices 2020 ·Heart Rhythm ·Hemal M. Nayak, Raj Patel, Scott McKane, (unknown), Timothy E. Meyer, Robin Germany, Christoph Stellbrink, Maria Rosa Costanzo, Ralph Augostini	1
13	Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea: A Pooled Cohort Analysis 2019 ·Journal of Clinical Sleep Medicine ·Marat Fudim, Andrew R. Spector, (unknown), Sean D. Pokorney, Robert J. Mentz, Dariusz Jagielski, Ralph Augostini, William T. Abraham, Piotr Ponikowski, Scott McKane, Jonathan P. Piccini	17
14	Phrenic nerve stimulation in patients with central sleep apnea: a single‑center experience from pilot and pivotal trials evaluating the remedē System 2019 ·Kardiologia Polska ·Dariusz Jagielski, Adam Kołodziej, (unknown), Bartosz Biel, Krzysztof Nowak, (unknown), (unknown), (unknown), (unknown), (unknown), Robin Germany, (unknown), Scott McKane, (unknown), William T. Abraham, Piotr Ponikowski	3
15	Phrenic Nerve Stimulation to Treat Patients with Central Sleep Apnoea and Heart Failure 2018 ·European Journal of Heart Failure ·Maria Rosa Costanzo, Piotr Ponikowski, Andrew J.S. Coats, Shahrokh Javaheri, Ralph Augostini, Lee R. Goldberg, Richard Holcomb, Andrew Kao, Rami Khayat, Olaf Oldenburg, Christoph Stellbrink, Scott McKane, William T. Abraham, (unknown)	59
16	Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors 2016 ·Oncology ·Emiliano Calvo, Fadi Braiteh, Daniel D. Von Hoff, Robert R. McWilliams, Carlos Becerra, Matthew D. Galsky, Gayle Jameson, Ji Lin, Scott McKane, Enaksha Wickremsinhe, Scott M. Hynes, Aimee Bence Lin, Karla Hurt, Donald Richards	33
17	A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors 2012 ·Cancer Chemotherapy and Pharmacology ·Michael S. Gordon, Robert Ilaria, Dinesh P. de Alwis, David S. Mendelson, Scott McKane, M M Wagner, Katherine Y. Look, Patricia LoRusso	13
18	Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic Keratosis 2005 ·Archives of Dermatology ·Neil J. Korman, (unknown), Mark Ling, Robert Matheson, Stacy Smith, Scott McKane, James H. Lee	127
19	Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial 2005 ·British Journal of Dermatology ·(unknown), R S Barnetson, (unknown), Scott McKane, (unknown), Herbert B. Slade, Gary M. Halliday	48
20	Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms 2004 ·Archives of Dermatological Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Scott McKane, (unknown)	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact